New angle on the CD95 receptor in cancer

Tuesday 1 June 2010

A team of researchers in the US has reported that the CD95 receptor promotes tumour growth, a finding that advances work done at the German Cancer Research Center in Heidelberg, and at its spin-out, Apogenix GmbH.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Germany